Lataa...

The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization

LTX-315 has been developed as an amphipathic cationic peptide that kills cancer cells. Here, we investigated the putative involvement of mitochondria in the cytotoxic action of LTX-315. Subcellular fractionation of LTX-315-treated cells, followed by mass spectrometric quantification, revealed that t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Zhou, Heng, Forveille, Sabrina, Sauvat, Allan, Sica, Valentina, Izzo, Valentina, Durand, Sylvère, Müller, Kevin, Liu, Peng, Zitvogel, Laurence, Rekdal, Øystein, Kepp, Oliver, Kroemer, Guido
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694939/
https://ncbi.nlm.nih.gov/pubmed/26378049
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!